Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-14

Clinical Trial Update: Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trials at Yale are investigating brain network changes associated with pharmacotherapy for obsessive-compulsive disorder and whether these ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Obsessive-Compulsive Disorder | Phase 1, Phase 2 | Status: RECRUITING